Expression and secretion of CXCL12 are enhanced in autosomal dominant polycystic kidney disease
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Autosomal dominant polycystic kidney disease (ADPKD), one of the most common human monogenic diseases (frequency of 1/1000-1/400), is characterized by numerous fluid-filled renal cysts (RCs). Inactivation of the PKD1 or PKD2 gene by germline and somatic mutations is necessary for cyst formation in ADPKD. To mechanistically understand cyst formation and growth, we isolated RCs from Korean patients with ADPKD and immortalized them with human telomerase reverse transcriptase (hTERT). Three hTERT-immortalized RC cell lines were characterized as proximal epithelial cells with germline and somatic PKD1 mutations. Thus, we first established hTERT-immortalized proximal cyst cells with somatic PKD1 mutations. Through transcriptome sequencing and Gene Ontology (GO) analysis, we found that upregulated genes were related to cell division and that downregulated genes were related to cell differentiation. We wondered whether the upregulated gene for the chemokine CXCL12 is related to the mTOR signaling pathway in cyst growth in ADPKD. CXCL12 mRNA expression and secretion were increased in RC cell lines. We then examined CXCL12 levels in RC fluids from patients with ADPKD and found increased CXCL12 levels. The CXCL12 receptor CXC chemokine receptor 4 (CXCR4) was upregulated, and the mTOR signaling pathway, which is downstream of the CXCL12/CXCR4 axis, was activated in ADPKD kidney tissue. To confirm activation of the mTOR signaling pathway by CXCL12 via CXCR4, we treated the RC cell lines with recombinant CXCL12 and the CXCR4 antagonist AMD3100; CXCL12 induced the mTOR signaling pathway, but the CXCR4 antagonist AMD3100 blocked the mTOR signaling pathway. Taken together, these results suggest that enhanced CXCL12 in RC fluids activates the mTOR signaling pathway via CXCR4 in ADPKD cyst growth.
Abstract
Autosomal dominant polycystic kidney disease (ADPKD), one of the most common human monogenic diseases (frequency of 1/1000-1/400), is characterized by numerous fluid-filled renal cysts (RCs). Inactivation of the PKD1 or PKD2 gene by germline and somatic mutations is necessary for cyst formation in ADPKD. To mechanistically understand cyst formation and growth, we isolated RCs from Korean patients with ADPKD and immortalized them with human telomerase reverse transcriptase (hTERT). Three hTERT-immortalized RC cell lines were characterized as proximal epithelial cells with germline and somatic PKD1 mutations. Thus, we first established hTERT-immortalized proximal cyst cells with somatic PKD1 mutations. Through transcriptome sequencing and Gene Ontology (GO) analysis, we found that upregulated genes were related to cell division and that downregulated genes were related to cell differentiation. We wondered whether the upregulated gene for the chemokine CXCL12 is related to the mTOR signaling pathway in cyst growth in ADPKD. CXCL12 mRNA expression and secretion were increased in RC cell lines. We then examined CXCL12 levels in RC fluids from patients with ADPKD and found increased CXCL12 levels. The CXCL12 receptor CXC chemokine receptor 4 (CXCR4) was upregulated, and the mTOR signaling pathway, which is downstream of the CXCL12/CXCR4 axis, was activated in ADPKD kidney tissue. To confirm activation of the mTOR signaling pathway by CXCL12 via CXCR4, we treated the RC cell lines with recombinant CXCL12 and the CXCR4 antagonist AMD3100; CXCL12 induced the mTOR signaling pathway, but the CXCR4 antagonist AMD3100 blocked the mTOR signaling pathway. Taken together, these results suggest that enhanced CXCL12 in RC fluids activates the mTOR signaling pathway via CXCR4 in ADPKD cyst growth.
참고문헌 (22)
- Peters DJ, "Autosomal dominant polycystic kidney disease : modification of disease progression", Lancet, 358, pp.1439~1444 (2001)
- Harris PC, "Polycystic kidney disease", Annu Rev Med, 60, pp.321~337 (2009)
- Ghata J, "Polycystic Kidney Disease", Compr Physiol, 7, pp.945~975 (2017)
- Sutters M, "Autosomal dominant polycystic kidney disease : molecular genetics and pathophysiology", J Lab Clin Med, 141, pp.91~101 (2003)
- Watnick TJ, "An unusual pattern of mutation in the duplicated portion of PKD1 is revealed by use of a novel strategy for mutation detection", Hum Mol Genet, 6, pp.1473~1481 (1997)
- Rossetti S, "Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing", J Am Soc Nephrol, 23, pp.915~933 (2012)
- Pei Y, "A "two-hit" model of cystogenesis in autosomal dominant polycystic kidney disease?", Trends Mol Med, 7, pp.151~156 (2001)
- Bodnar AG, "Extension of life-span by introduction of telomerase into normal human cells", Science, 279, pp.349~352 (1998)
- Counter CM, "Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization", Proc Natl Acad Sci U S A, 95, pp.14723~14728 (1998)
- Lee KM, "Use of exogenous hTERT to immortalize primary human cells", Cytotechnology, 45, pp.33~38 (2004)
- Ouellette MM, "The establishment of telomeraseimmortalized cell lines representing human chromosome instability syndromes", Hum Mol Genet, 9, pp.403~411 (2000)
- Hein J, "Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding", J Virol, 83, pp.117~127 (2009)
- Shirozu M, "Structure and chromosomal localization of the human stromal cellderived factor 1(SDF1)gene", Genomics, 28, pp.495~500 (1995)
- Nagasawa T, "CXC chemokine ligand 12(CXCL12)and its receptor CXCR4", J Mol Med, 92, pp.433~439 (2014)
- Sánchez-Martín L, "CXCR7 impact on CXCL12 biology and disease", Trends Mol Med, 19, pp.12~22 (2013)
- Liekens S, "CXCL12-CXCR4axis in angiogenesis, metastasis and stem cell mobilization", Curr Pharm Des, 16, pp.3903~3920 (2010)
- Guyon A, "CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems", Front Cell Neurosci, 8, pp.65~ (2014)
- Ghanem I, "Insights on the CXCL12-CXCR4axis in hepatocellular carcinoma carcinogenesis", Am J Transl Res, 6, pp.340~352 (2014)
- Scala S, "Molecular Pathways : Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment", Clin Cancer Res, 21, pp.4278~4285 (2015)
- Herbert BS, "A telomerase immortalized human proximal tubule cell line with a truncation mutation(Q4004X)in polycystin-1", PLoS One, 8, pp.e55191~ (2013)
- Tan YC, "Novel method for genomic analysis of PKD1 and PKD2mutations in autosomal dominant polycystic kidney disease", Hum Mutat, 30, pp.264~273 (2009)
- 조효상, "Effects of PEP-1-FK506BP on cyst formation in polycystic kidney disease", BMB Reports, 50(9), pp.460~465 (2017), 생화학분자생물학회